Spectrum Pharmaceuticals, Inc. An International Commercial-Stage Biotechnology Company
Spectrum Pharmaceuticals, Inc. An International Commercial-Stage Biotechnology Company

Insider Transactions

Date Name Title Type Shares Traded Price Range
Mar 22, 2017
President & COO
President & COO Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 3,419 $6.42
Feb 18, 2017
EVP & Chief Financial Officer
EVP & Chief Financial Officer Other acquisition or disposition -- --
Feb 18, 2017
EVP & Chief Financial Officer
EVP & Chief Financial Officer Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 2,471 $5.91
Feb 18, 2017
Director, Chairman & CEO, Ten Percent Owner
Director, Chairman & CEO, Ten Percent Owner Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 6,939 $5.91
Feb 18, 2017
Director, Chairman & CEO, Ten Percent Owner
Director, Chairman & CEO, Ten Percent Owner Other acquisition or disposition -- --
Feb 18, 2017
Director, Chairman & CEO, Ten Percent Owner
Director, Chairman & CEO, Ten Percent Owner Other acquisition or disposition -- --
Feb 18, 2017
Director, Chairman & CEO, Ten Percent Owner
Director, Chairman & CEO, Ten Percent Owner Other acquisition or disposition -- --
Feb 18, 2017
Director, Chairman & CEO, Ten Percent Owner
Director, Chairman & CEO, Ten Percent Owner Other acquisition or disposition -- --
Feb 18, 2017
Director, Chairman & CEO, Ten Percent Owner
Director, Chairman & CEO, Ten Percent Owner Other acquisition or disposition -- --
Feb 18, 2017
President & COO
President & COO Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 4,026 $5.91
Dec 31, 2016
Director
Director Bona fide gift 2,500 --
Dec 31, 2016
Director
Director Bona fide gift 5,000 --
Dec 31, 2016
Director
Director Bona fide gift 2,500 --
Dec 31, 2016
Director, Chairman & CEO, Ten Percent Owner
Director, Chairman & CEO, Ten Percent Owner Bona fide gift 10,613 --
Dec 31, 2016
Director, Chairman & CEO, Ten Percent Owner
Director, Chairman & CEO, Ten Percent Owner Other acquisition or disposition -- --
Dec 31, 2016
Director, Chairman & CEO, Ten Percent Owner
Director, Chairman & CEO, Ten Percent Owner Bona fide gift 10,613 --
Dec 31, 2016
Director, Chairman & CEO, Ten Percent Owner
Director, Chairman & CEO, Ten Percent Owner Other acquisition or disposition -- --
Dec 31, 2016
Director, Chairman & CEO, Ten Percent Owner
Director, Chairman & CEO, Ten Percent Owner Other acquisition or disposition -- --
Dec 31, 2016
Director, Chairman & CEO, Ten Percent Owner
Director, Chairman & CEO, Ten Percent Owner Bona fide gift 6,000 --
Dec 31, 2016
Director, Chairman & CEO, Ten Percent Owner
Director, Chairman & CEO, Ten Percent Owner Other acquisition or disposition -- --
Dec 31, 2016
Director, Chairman & CEO, Ten Percent Owner
Director, Chairman & CEO, Ten Percent Owner Bona fide gift 4,320 --
Dec 31, 2016
Director, Chairman & CEO, Ten Percent Owner
Director, Chairman & CEO, Ten Percent Owner Bona fide gift 9,000 --
Dec 03, 2016
President & COO
President & COO Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 1,710 $4.00
Oct 29, 2016
President & COO
President & COO Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 1,710 $3.67
Jun 27, 2016
Director
Director Grant, award or other acquisition pursuant to Rule 16b-3(d) 10,000 --

* Represents the number of non-derivative securities directly held. (I) Indicates that some (or all) of these shares are held indirectly.

Back to top

Spectrum Pharmaceuticals, Inc. An International Commercial-Stage Biotechnology Company

Copyright Nasdaq. Minimum 15 minutes delayed.